Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting

References

• DateAAHanesJEnsignLMNanoparticles for oral delivery: design, evaluation and state-of-the-artJ Control Release201624050452627292178
   PubMed Web of Science ®Google Scholar
• YuMYangYZhuCGuoSGanYAdvances in the transepithelial transport of nanoparticlesDrug Discov Today20162171155116127196527
   PubMed Web of Science ®Google Scholar
• LiYHongJLiHGenkwanin nanosuspensions: a novel and potential antitumor drug in breast carcinoma therapyDrug Deliv20172411491150028961040
   PubMed Web of Science ®Google Scholar
• LiLJiangGYuWPreparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulinMater Sci Eng C Mater Biol Appl201770pt 127828627770892
   PubMed Web of Science ®Google Scholar
• DudhipalaNVeerabrahmaKImproved anti-hyperlipidemic activity of rosuvastatin calcium via lipid nanoparticles: pharmacokinetic and pharmacodynamic evaluationEur J Pharm Biopharm2017110475727810472
   PubMed Web of Science ®Google Scholar
• JoycePYasminRBhattABoydBJPhamAPrestidgeCAComparison across three hybrid lipid-based drug delivery systems for improving the oral absorption of the poorly water-soluble weak base cinnarizineMol Pharm201714114008401828950059
   PubMed Web of Science ®Google Scholar
• GrigorasAGPolymer-lipid hybrid systems used as carriers for insulin deliveryNanomedicine20171382425243728821465
   PubMed Web of Science ®Google Scholar
• FlorekJCaillardRKleitzFEvaluation of mesoporous silica nanoparticles for oral drug delivery – current status and perspective of MSNs drug carriersNanoscale2017940152521527728984885
   PubMed Web of Science ®Google Scholar
• RanFLeiWCuiYSize effect on oral absorption in polymer-functionalized mesoporous carbon nanoparticlesJ Colloid Interface Sci2018511576628972896
   PubMed Web of Science ®Google Scholar
• RenTWangQXuYEnhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticlesJ Control Release201726942343829133120
   PubMed Web of Science ®Google Scholar
• MenzelCBernkop-SchnurchAEnzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrierAdv Drug Deliv Rev201712416417429079537
   PubMed Web of Science ®Google Scholar
• BeloquiASolinísMÁdes RieuxAPréatVRodríguez-GascónADextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugsInt J Pharm20144681–210511124746410
   PubMedGoogle Scholar
• MandracchiaDTrapaniATripodoGIn vitro evaluation of glycol chitosan based formulations as oral delivery systems for efflux pump inhibitionCarbohydr Polym2017166738228385250
   PubMed Web of Science ®Google Scholar
• FanWXiaDZhuQFunctional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin deliveryBiomaterials2018151132329055774
   PubMed Web of Science ®Google Scholar
• PaulPKNopparatJNuanplubMTreetongASuedeeRImprovement in insulin absorption into gastrointestinal epithelial cells by using molecularly imprinted polymer nanoparticles: microscopic evaluation and ultrastructureInt J Pharm20175301–227929028764982
   PubMedGoogle Scholar
• PaulPKTreetongASuedeeRBiomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery systemActa Pharm201767214916828590908
   PubMed Web of Science ®Google Scholar
• IglesiasTLopez de CerainAIracheJMEvaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug deliveryInt J Pharm20175171–2677927908629
   PubMedGoogle Scholar
• PatelPShahJSafety and toxicological considerations of nanomedicines: the future directionsCurr Clin Pharmacol2017122738228486906
   PubMed Web of Science ®Google Scholar
• SaifiMAKhanWGoduguCCytotoxicity of nanomaterials: nano-toxicology to address the safety concerns of nanoparticlesPharm Nanotechnol201761316
   Google Scholar
• HeurtaultBSaulnierPPechBProustJEBenoitJPA novel phase inversion-based process for the preparation of lipid nanocarriersPharm Res200219687588012134960
   PubMed Web of Science ®Google Scholar
• RogerELagarceFBenoitJPThe gastrointestinal stability of lipid nanocapsulesInt J Pharm2009379226026519524655
   PubMed Web of Science ®Google Scholar
• RogerELagarceFBenoitJPDevelopment and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administrationEur J Pharm Biopharm201179118118821303693
   PubMed Web of Science ®Google Scholar
• GrooACSaulnierPGimelJCFate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral deliveryInt J Nanomedicine201384291430224235827
   PubMed Web of Science ®Google Scholar
• RogerELagarceFGarcionEBenoitJPLipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosisJ Control Release2009140217418119699246
   PubMed Web of Science ®Google Scholar
• RogerELagarceFGarcionEBenoitJPReciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cellsEur J Pharm Sci201040542242920438839
   PubMed Web of Science ®Google Scholar
• Le RouxGMocheHNietoABenoitJPNesslanyFLagarceFCytotoxicity and genotoxicity of lipid nanocapsulesToxicol In Vitro20174118919928323104
   PubMed Web of Science ®Google Scholar
• MaupasCMoulariBBeduneauALamprechtAPellequerYSurfactant dependent toxicity of lipid nanocapsules in HaCaT cellsInt J Pharm20114111–213614121463666
   PubMed Web of Science ®Google Scholar
• PeltierSOgerJMLagarceFCouetWBenoitJPEnhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsulesPharm Res20062361243125016715372
   PubMed Web of Science ®Google Scholar
• RamadanALagarceFTessier-MarteauAOral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic studyInt J Nanomedicine201162941295122162653
   PubMed Web of Science ®Google Scholar
• EissaMMEl-MoslemanyRMRamadanAAAmerEIEl-AzzouniMZEl-KhordaguiLKMiltefosine lipid nanocapsules for single dose oral treatment of schistosomiasis mansoni: a preclinical studyPLoS One20151011e014178826574746
   PubMed Web of Science ®Google Scholar
• OlliaroPDelgado-RomeroPKeiserJThe little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)J Antimicrob Chemother201469486387024390933
   PubMed Web of Science ®Google Scholar
• YangLGengYHLiHZhangYYouJSChangYYEnhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticlesPharmazie2009642868919320279
   PubMed Web of Science ®Google Scholar
• XieSYPanBLWangMFormulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticlesNanomedicine20105569370120662641
   PubMed Web of Science ®Google Scholar
• MouraoSCCostaPISalgadoHRNGremiaoMPDImprovement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomesInt J Pharm20052951–215716215848000
   PubMedGoogle Scholar
• FrezzaTFGremiaoMPDZanotti-MagalhaesEMMagalhaesLAde SouzaALRAllegrettiSMLiposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assayActa Trop20131281707523811113
   PubMed Web of Science ®Google Scholar
• CongZShiYPengXDesign and optimization of thermosensitive nanoemulsion hydrogel for sustained-release of praziquantelDrug Dev Ind Pharm201743455857327935330
   PubMed Web of Science ®Google Scholar
• PetersPAWarrenKSA rapid method of infecting mice and other laboratory animals with Schistosoma mansoni: subcutaneous injectionJ Parasitol1969553558
   Web of Science ®Google Scholar
• SmithersSRTerryRJThe infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult wormsParasitology19655546957004957633
   PubMedGoogle Scholar
• FigueiroFde OliveiraCPRockenbachLPharmacological improvement and preclinical evaluation of methotrexate-loaded lipid-core nanocapsules in a glioblastoma modelJ Biomed Nanotechnol201511101808181826502643
   PubMed Web of Science ®Google Scholar
• WebsterJPMolyneuxDHHotezPJFenwickAThe contribution of mass drug administration to global health: past, present and futurePhilos Trans R Soc Lond B Biol Sci201436916452013043424821920
   PubMed Web of Science ®Google Scholar
• MuchirahPJYoleDKutimaHWaihenyaRMunaKJohnMDetermination of effective praziquantel dose in different mouse strains: BALB/C and swiss mice in treatment of Schistosoma mansoniJ Clin Immnunol Immunopathol Res20124212
   Google Scholar
• CarboneCMusumeciTLauroMRPuglisiGEco-friendly aqueous core surface-modified nanocapsulesColloids Surf B Biointerfaces201512519019625497291
   PubMed Web of Science ®Google Scholar
• MallyMPeterlinPSvetinaSPartitioning of oleic acid into phosphatidylcholine membranes is amplified by strainJ Phys Chem B201311740120861209424000876
   PubMed Web of Science ®Google Scholar
• NiuZTedescoEBenettiFRational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriersJ Control Release201726341728235590
   PubMed Web of Science ®Google Scholar
• TalegaonkarSAzeemAAhmadFJKharRKPathanSAKhanZIMicroemulsions: a novel approach to enhanced drug deliveryRecent Pat Drug Deliv Formul20082323825719075911
   PubMedGoogle Scholar
• LinJMoriFEffect of polar components on phase inversion temperatures in systems containing nonionic surfactants and nonpolar oilsJ Korean Ind Eng Chem199452274284
   Google Scholar
• PenselPEUllio GamboaGFabbriJCystic echinococcosis therapy: albendazole-loaded lipid nanocapsules enhance the oral bio-availability and efficacy in experimentally infected miceActa Trop201515218519426409727
   PubMed Web of Science ®Google Scholar
• ZhengXSDuanCZXiaoZDYaoBATransdermal delivery of praziquantel: effects of solvents on permeation across rabbit skinBiol Pharm Bull20083151045104818451545
   PubMed Web of Science ®Google Scholar
• XiaoSHShenBGCholletJTannerMTegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemetherActa Trop200075334134810838218
   PubMed Web of Science ®Google Scholar
• El-MoslemanyRMEissaMMRamadanAAEl-KhordaguiLKEl-AzzouniMZMiltefosine lipid nanocapsules: intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoniActa Trop201615914214827039667
   PubMed Web of Science ®Google Scholar
• GamboaGVPalmaSDLifschitzAIvermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applicationsParasitol Res201611551945195326852126
   PubMed Web of Science ®Google Scholar
• PablaDAkhlaghiFZiaHIntestinal permeability enhancement of levothyroxine sodium by straight chain fatty acids studied in MDCK epithelial cell lineEur J Pharm Sci201040546647220580671
   PubMed Web of Science ®Google Scholar
• El-FahamMHEissaMMIgeteiJETreatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigensPLoS Negl Trop Dis2017118e000585328841653
   PubMed Web of Science ®Google Scholar
• KatoKWaldePKoineNTemperature-sensitive nonionic vesicles prepared from Span 80 (sorbitan monooleate)Langmuir20082419107621077018720959
   PubMed Web of Science ®Google Scholar
• AblaNKeiserJVargasMReimersNHaasHSpangenbergTEvaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse modelPLoS Negl Trop Dis2017119e000594228934207
   PubMed Web of Science ®Google Scholar
• SerranoDRLalatsaADea-AyuelaMAOral particle uptake and organ targeting drives the activity of amphotericin B nanoparticlesMol Pharm201512242043125558881
   PubMed Web of Science ®Google Scholar
• RogerEGimelJCBensleyCKlymchenkoASBenoitJPLipid nanocapsules maintain full integrity after crossing a human intestinal epithelium modelJ Control Release2017253111828274740
   PubMed Web of Science ®Google Scholar
• TobioMSanchezAVilaAThe role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administrationColloids Surf B Biointerfaces2000183–431532310915953
   PubMed Web of Science ®Google Scholar
• GrooACMirchevaKBejaudJDevelopment of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsulesPharm Res20143171753176524469905
   PubMed Web of Science ®Google Scholar
• Cury-BoaventuraMFGorjaoRde LimaTMNewsholmePCuriRComparative toxicity of oleic and linoleic acid on human lymphocytesLife Sci200678131448145616236329
   PubMed Web of Science ®Google Scholar
• EiblHUngerCFleerEAMKimDJBergerMRNagelGAHexadecylphosphocholine, a new antineoplastic agent: cytotoxic properties in leukaemic cellsJ Cancer Res Clin Oncol1986111S24
   Google Scholar
• UngerCDamenzWFleerEAHexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivoActa Oncol19892822132172736110
   PubMed Web of Science ®Google Scholar
• de SouzaALAndreaniTde OliveiraRNIn vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatmentInt J Pharm20144631313724370839
   PubMedGoogle Scholar